Clinical Trial Update: Molecular Imaging Modality by Positron Emission Tomography Using 18F-X : Study of Microglial Activation in Amyotrophic Lateral Sclerosis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating an 18F-labeled PET imaging tracer to visualize microglial activation in amyotrophic lateral sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• 18F-X PET tracer (18F-X)

Snippet

Sponsor: University Hospital, Tours | Conditions: Amyotrophic Lateral Sclerosis, Bulbar Disease | Phase 1 | Status: UNKNOWN